A Role for H2S in the microcirculation of newborns: the major metabolite of H2S (thiosulphate) is increased in preterm infants by Dyson, Rebecca M et al.
University of Wollongong 
Research Online 
Faculty of Science, Medicine and Health - 
Papers: part A Faculty of Science, Medicine and Health 
1-1-2014 
A Role for H2S in the microcirculation of newborns: the major metabolite of 
H2S (thiosulphate) is increased in preterm infants 
Rebecca M. Dyson 
University of Wollongong, rdyson@uow.edu.au 
Hannah K. Palliser 
University of Newcastle 
Joanna L. Latter 
Hunter Medical Research Institute 
Grazyna Chwatko 
University of Lodz 
Rafal Glowacki 
University of Lodz 
See next page for additional authors 
Follow this and additional works at: https://ro.uow.edu.au/smhpapers 
 Part of the Medicine and Health Sciences Commons, and the Social and Behavioral Sciences 
Commons 
Recommended Citation 
Dyson, Rebecca M.; Palliser, Hannah K.; Latter, Joanna L.; Chwatko, Grazyna; Glowacki, Rafal; and Wright, 
Ian M. R, "A Role for H2S in the microcirculation of newborns: the major metabolite of H2S (thiosulphate) 
is increased in preterm infants" (2014). Faculty of Science, Medicine and Health - Papers: part A. 2122. 
https://ro.uow.edu.au/smhpapers/2122 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
A Role for H2S in the microcirculation of newborns: the major metabolite of H2S 
(thiosulphate) is increased in preterm infants 
Abstract 
Excessive vasodilatation during the perinatal period is associated with cardiorespiratory instability in 
preterm neonates. Little evidence of the mechanisms controlling microvascular tone during circulatory 
transition exists. We hypothesised that hydrogen sulphide (H2S), an important regulator of microvascular 
reactivity and central cardiac function in adults and animal models, may contribute to the vasodilatation 
observed in preterm newborns. Term and preterm neonates (24-43 weeks gestational age) were studied. 
Peripheral microvascular blood flow was assessed by laser Doppler. Thiosulphate, a urinary metabolite of 
H2S, was determined by high performance liquid chromatography as a measure of 24 hr total body H2S 
turnover for the first 3 days of postnatal life. H2S turnover was greatest in very preterm infants and 
decreased with increasing gestational age (p = 0.0001). H2S turnover was stable across the first 72 hrs of 
life in older neonates. In very preterm neonates, H2S turnover increased significantly from day 1 to 3 (p = 
0.0001); and males had higher H2S turnover than females (p = 0.04). A significant relationship between 
microvascular blood flow and H2S turnover was observed on day 2 of postnatal life (p = 0.0004). H2S 
may play a role in maintaining microvascular tone in the perinatal period. Neonates at the greatest risk of 
microvascular dysfunction characterised by inappropriate peripheral vasodilatation - very preterm male 
neonates - are also the neonates with highest levels of total body H2S turnover suggesting that 
overproduction of this gasotransmitter may contribute to microvascular dysfunction in preterms. 
Potentially, H2S is a target to selectively control microvascular tone in the circulation of newborns. 
Disciplines 
Medicine and Health Sciences | Social and Behavioral Sciences 
Publication Details 
Dyson, R. M., Palliser, H. K., Latter, J. L., Chwatko, G., Glowacki, R. & Wright, I. M. R. (2014). A Role for H2S 
in the microcirculation of newborns: the major metabolite of H2S (thiosulphate) is increased in preterm 
infants. PLoS One, 9 (8), e105085-1-e105085-9. 
Authors 
Rebecca M. Dyson, Hannah K. Palliser, Joanna L. Latter, Grazyna Chwatko, Rafal Glowacki, and Ian M. R 
Wright 
This journal article is available at Research Online: https://ro.uow.edu.au/smhpapers/2122 
A Role for H2S in the Microcirculation of Newborns: The
Major Metabolite of H2S (Thiosulphate) Is Increased in
Preterm Infants
Rebecca M. Dyson1,2,3, Hannah K. Palliser1,4, Joanna L. Latter1,5, Grazyna Chwatko6, Rafal Glowacki6,
Ian M. R. Wright1,2,3,7*
1Mothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, 2Discipline of Paediatrics and Child Health, School of
Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, 3 Illawarra Health and Medical Research Institute and Graduate School of Medicine,
University of Wollongong, Wollongong, NSW, Australia, 4 School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, 5Discipline of
Public Health, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, 6Department of Environmental Chemistry, Faculty of Chemistry,
University of Lodz, Lodz, Poland, 7 Kaleidoscope Neonatal Intensive Care Unit, John Hunter Children’s Hospital, New Lambton Heights, NSW, Australia
Abstract
Excessive vasodilatation during the perinatal period is associated with cardiorespiratory instability in preterm neonates.
Little evidence of the mechanisms controlling microvascular tone during circulatory transition exists. We hypothesised that
hydrogen sulphide (H2S), an important regulator of microvascular reactivity and central cardiac function in adults and
animal models, may contribute to the vasodilatation observed in preterm newborns. Term and preterm neonates (24–43
weeks gestational age) were studied. Peripheral microvascular blood flow was assessed by laser Doppler. Thiosulphate, a
urinary metabolite of H2S, was determined by high performance liquid chromatography as a measure of 24 hr total body
H2S turnover for the first 3 days of postnatal life. H2S turnover was greatest in very preterm infants and decreased with
increasing gestational age (p = 0.0001). H2S turnover was stable across the first 72 hrs of life in older neonates. In very
preterm neonates, H2S turnover increased significantly from day 1 to 3 (p = 0.0001); and males had higher H2S turnover than
females (p = 0.04). A significant relationship between microvascular blood flow and H2S turnover was observed on day 2 of
postnatal life (p = 0.0004). H2S may play a role in maintaining microvascular tone in the perinatal period. Neonates at the
greatest risk of microvascular dysfunction characterised by inappropriate peripheral vasodilatation - very preterm male
neonates - are also the neonates with highest levels of total body H2S turnover suggesting that overproduction of this
gasotransmitter may contribute to microvascular dysfunction in preterms. Potentially, H2S is a target to selectively control
microvascular tone in the circulation of newborns.
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Introduction
Hypotension and low cardiac output complicate the course of
very preterm infants, mostly in the first 48 hrs [1]. Preterm male
infants ,29 weeks gestation have significantly lower mean arterial
blood pressure at 12–24 hrs, require more inotropic support and
have more resistant hypotension than females [2]. Measurement of
superior vena caval flow suggests that abnormal regulation of
vascular resistance plays a role [3], with inappropriate microvas-
cular vasodilatation playing a major role in the development of
hypotension. We previously demonstrated a significant relation-
ship between microvascular dilatation, mean arterial pressure and
poor outcome in a preterm neonatal population [4]. Furthermore,
we identified a sexually dimorphic pattern in microvascular
function - very preterm male infants have greater vasodilatation
than female infants of the same gestational age at 24 h postnatal
age [5], suggesting a sex-specific difference in the neonatal ability
to control vascular tone. This may explain why males are more at
risk of complications following premature birth – male preterm
infants are at much greater risk of dying or suffering from chronic
neurodevelopmental disability [6,7]. The death rate for extremely
preterm males is more than double that of females (26% vs. 12%)
and male morbidity is reflected by a 13% increased length of stay
and increased re-admissions within the first year of life [6,8].
Recent evidence suggests that a mismatch between vasocon-
strictor and vasodilator molecules in the preterm newborn may
underlie these microvascular blood flow problems. For example, it
has been shown that the relative expression of vasoconstrictors
such as norepinephrine (highest in females and more mature
infants), is associated with lower microvascular flow and greater
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physiological stability [9]. Conversely vasodilators, specifically
markers for the gasotransmitters nitric oxide (NO) and carbon
monoxide (CO), are highest in males and younger infants, i.e.
those who exhibit increased vasodilatation [10]. However, the
increases seen in NO occur outside the crucial early period of the
first 24–48 hours. Furthermore, changes in CO only explain a
proportion of the variance we measured in early vasodilator
events. These results suggest another factor must play a significant
role in aberrant vasodilation.
Hydrogen sulphide (H2S) has recently been of considerable
interest in adult health and disease, with H2S identified as an
important gaseous regulatory molecule with many biological and
physiological roles, including synaptic modulation, neuroprotec-
tion and smooth muscle relaxation [11]. H2S is endogenously
produced in amounts capable of causing vasodilatation, thus
controlling blood pressure [12]. Despite compelling adult data,
almost nothing is known about the role of H2S in the transitional
circulation of the neonate. Its contribution to vasodilatation may
be crucial for regulation and dysfunction of vascular tone in the
neonate. A recent piglet study suggests that H2S may be important
in at least the transitional cerebral circulation [13]. These data,
combined with our observations on NO and CO, led us to
hypothesize that H2S would contribute to the excessive vasodila-
tation observed in preterm neonates in the initial extrauterine
period. Specifically, that H2S production would be greater in those
infants at greatest risk of microvascular dysfunction – very preterm
male neonates – and that levels would correlate with microvas-
cular blood flow.
One of the major challenges in translating preclinical animal
studies to humans is determining a robust, non-invasive method to
measure disturbances in H2S signaling. Due to the short half-life
and volatile nature of the gas, we pursued an indirect metabolic
measure [14]. The metabolism of H2S can be divided into three
distinct pathways: oxidation to sulphate, clearance by exhalation
and reactions with metalloproteins and disulphide containing
proteins. Oxidation to sulphate and subsequent excretion by the
kidneys represents the major metabolic and excretory pathway,
with urinary sulphate levels representing around 50% of an
exogenous dose of H2S administered orally, subcutaneously,
intraperitoneally or intravenously [15]. Sulphate is not a suitable
analytical target as production from other sources of sulphur
swamp the contribution of H2S [14]. Urinary thiosulphate, an
intermediate of the breakdown of H2S to sulphate is routinely used
as a marker of exposure to high H2S levels in cases of industrial or
environmental exposure and thus represents a better analytical
target when the issue is total body turnover of H2S [16,17]. Such
non-invasive measures, if sensitive enough to detect endogenous
H2S production, are suitable for clinical monitoring where tissues
for analysis of enzyme expression and activity are not available.
The aim of the present study was to measure H2S output (as
thiosulphate) in newborns, characterise levels in relation to
gestational age, postnatal age and sex and to assess whether H2S
turnover was associated with microvascular blood flow; the latter
having previously been shown to correlate strongly with clinical
illness severity and physiological stability in the sick newborn
human infant [4].
Table 1. Clinical Characteristics of Neonates.
Very Preterm Group Preterm Group Term Group
Female (n=20) Male (n=16) Female (n =19) Male (n =24) Female (n =6) Male (n =5)
Gestation (wk) 26 (24–28) 26.5 (24–28) 32 (29–35) 31 (29–35) 38.5 (38–41) 39 (38–43)
Birth weight (kg) 0.87 (0.6–1.4) 1.0 (0.6–1.4)* 1.76 (1.0–2.4) 1.65 (0.9–2.8) 3.34 (3.0–4.0) 4.2 (3.3–4.3)
Multiple Birth (n, %) 2 (10%) 7 (44%)* 6 (32%) 11 (46%) 0 0
Completed antenatal steroids (n, %) 14 (70%) 13 (81%) 12 (63%) 18 (75%) 1 (16%) 0
Maternal Chorioamnionitis (n, %) 2 (10%) 1 (6%) 1 (5%) 2 (8%) 0 0
Maternal Smoking (n, %) 4 (20%) 3 (19%) 4 (21%) 5 (21%) 0 0
Pregnancy-induced Hypertension (n, %) 0 2 (13%) 2 (11%) 2 (8%) 0 0
Small for gestational age (n, %) 0 0 0 2 (8%) 1 (16%) 0
Vaginal delivery (n, %) 10 (50%) 7 (44%) 11 (58%) 11 (46%) 4 (67%) 4 (80%)
5-min APGAR score 8 (4–10) 8 (5–10) 9 (5–10) 9 (5–10) 9 9 (9–10)
CRIB II score 11 (8–15) 10 (7–16) 3 (1–8) 4 (1–8) 3 -
Mean Blood Pressure at 24 h (mmHg) 35 (24–43){ 36 (31–46) 50 (30–81) 39.5 (30–81)* - -
Mechanical ventilation (hr) 0 (0–20) 0 (0–24) 0 (0–10) 0 (0–2) - -
CPAP (hr) 3 (0–14) 1.5 (0–20) 0 (0–19) 0 (0–16) - -
Patent Ductus Arteriosus (n, %) 10 (50%) 6 (38%) 1 (5%) 3 (13%) 0 0
Sepsis (n, %) 6 (30%) 8 (50%) 3 (16%) 2 (8%) 0 0
IVH . grade II (n, %) 1 (5%) 2 (13%) 1 (5%) 0 0 0
Death (n, %) 4 (20%) 2 (13%) 0 0 0 0
Data presented as median (minimum-maximum) or number (%). APGAR Score – scores 7 and above are generally regarded as normal, 4 to 6 fairly low and 3 and below
critically low; CRIB II Score – Clinical Risk Index for Babies II, higher scores reflect poorer physiological stability; CPAP – Continuous Positive Air Pressure respiratory
support; Patent Ductus Arteriosus refers to a hemodynamically significant duct diagnosed in first 72 hrs; IVH – intraventricular hemorrhage greater than grade II
(significant IVH); Mean Blood Pressure reported is that at 24 h postnatal age and was not assessed in term controls; Death is those infants that survived to 72 h postnatal
age but died prior to discharge.
*significantly different from females of the same gestational age group p,0.05;
{significantly different from preterm neonates, within sex.
doi:10.1371/journal.pone.0105085.t001
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Materials and Methods
Subjects
The ‘‘Cardiovascular Adaptation of the Newborn Study 2
(CANS2)’’ was conducted at the John Hunter Children’s Hospital,
Newcastle, Australia between September 2008 and April 2011.
This study was approved by the Human Research Ethics
Committees of the Hunter New England Area Health Service
and the University of Newcastle. Parental informed, written
consent was obtained prior to investigation. Recruitment was
stratified a priori to neonates born at 28 weeks gestational age
(GA) or less (very preterm neonates), neonates born at 29–36
weeks (preterm neonates) and those born at 37+ weeks completed
gestation (term neonates). Hypoxic ischemic encephalopathy,
congenital malformations, chromosomal disorders or known
congenital infection excluded admission to this study. Methods
for recording of clinical and physiologic variables have been
reported previously [4].
Microvascular Studies
Laser Doppler is the best-established method of assessing
peripheral microvascular function [18]. Low-intensity laser light
is reflected by moving cells in the peripheral cutaneous circulation,
enabling measurement of both number and velocity of blood cells
moving through the skin microcirculatory bed, giving a measure of
peripheral microvascular blood flow in Perfusion Units (PU). For
laser Doppler assessment we used a Periflux 5001 laser Doppler
(Perimed AB, Jarfalla, Sweden) with a temperature-regulated
probe (Probe 457, Perimed) sited on the lateral aspect of the
neonates’ lower limb. Investigations were performed at 6, 24 and
72 hr postnatal age as previously described [5]. Briefly, basal
peripheral microvascular blood flow was recorded for 5 minutes
before lower limb blood flow was occluded using a sphygmoma-
nometer cuff to produce a 1-minute period of absent flow. This
allowed biological zero to be obtained, which was subtracted from
the basal blood flow in each experiment, allowing comparison
between different studies and subjects.
A significant interaction of gestational age and sex was observed
for total body turnover of H2S. In very preterm (24–28 wk)
neonates, H2S turnover in the first three days of postnatal life was
higher in males than in females (p = 0.04; Figure 3). Post hoc
analysis revealed this was due to higher H2S turnover in very
preterm males compared to females of the same gestational age
group on both day 1 (p = 0.01) and day 2 (p= 0.04) of postnatal
life.
Urine collection and Analysis
Twenty-four hour urine samples were collected on days 1–3 of
postnatal life as previously described [9]. Disposable diapers of the
appropriate size containing a pure cellulose pad were used for
urine collection. Diapers were changed every 4–6 hours as
clinically appropriate and collected in a plastic bag at 4uC until
completion of a 24 hr collection period then folded inside out and
the urine extracted using a specially constructed press. Each 24 hrs
of pooled specimens were stored at 280uC and spun before
analysis. Exact 24 hr urinary output was calculated by weighing
diapers before and after use. As humidity can contribute to diaper
weight, the degree and length of time in humidity were recorded
and adjustments were made as appropriate [19]. The corrected
values were used for 24 hr output values for analysis. Assessment of
urinary creatinine was carried out by Hunter Area Pathology
Services using the CREA method (a modification of the kinetic
Jaffe reaction) with Flex reagent cartridges (Siemens Healthcare
Diagnostics Inc., Camberley, United Kingdom) on the Dimension
Vista System (Siemens).
Thiosulphate measurement
Determination of thiosulphate in neonatal urine was based on
derivatisation with 2-chloro-1-methylquinolinium tetrafluorobo-
rate and separation and quantification of derivative by reversed-
phase liquid chromatography. A Hewlett-Packard 1100 Series
system (Waldbronn, Germany) with a Zorbax SB-C18
(150 mm64.6 mm, 5 mm) column (Agilent Technologies), con-
trolled by ChemStation software (Hewlett-Packard) was used as
described previously [20]. Briefly, isocratic elution, with a mobile
phase consisting of a mixture of acetonitrile and water in the ratio
of 60:40 (v/v), was used. Temperature was set at 25uC, the flow-
rate 1 mL/min and the detector wavelength 375 nm. Identifica-
tion of peaks was based on comparison of retention times and
diode-array spectra, taken at time of analysis, with corresponding
sets of data obtained for authentic compounds.
Urinary creatinine is a commonly used index to adjust for renal
function, however, the creatinine ratio often used in adults may be
unsuitable for neonates because of low excretion of creatinine in
infants [21]. Early studies observed a six-fold variance in
creatinine excretion between individuals less than 1 year postnatal
age. Furthermore, a wide variation in daily creatinine output was
also observed in infants, and this has been attributed to individual
metabolic variation [22]. In order to overcome this, 24 hr
excretion values for urinary thiosulphate were calculated relative
to 24 hr urinary output (mL/24 hr) and body weight (kg) in this
study. Therefore, total body turnover of H2S is expressed as nmol/
24 hr/kg for day 1, 2 and 3 of postnatal life. The same
relationships, as presented for the output/kg analyses, were
observed when corrected to 24 hr urinary creatinine and are thus
not reported.
Day 2 H2S turnover was significantly correlated with micro-
vascular blood flow at 24 h postnatal age (p = 0.0004, r=0.37).
This was largely due to preterm male neonates (p = 0.04, r=0.43;
figure 4) and was not observed in female neonates of the same
gestational age group (p = 0.97, r=20.01) or term neonates
(p = 0.82, r=20.08). No correlation was observed in very preterm
neonates alone (p = 0.28, r=0.19), despite neonates in this group
having the highest levels of both microvascular blood flow and
H2S turnover. In the preterm neonatal group (29–36 weeks GA),
H2S turnover was negatively correlated with both systolic
(p = 0.01, r=20.39) and diastolic (0.04, r=20.33) blood pressure
on day 2 of postnatal life. No relationship was observed in the very
preterm neonatal group (systolic: p = 0.33, r=0.17; diastolic:
p = 0.25, r=0.20).
Statistical methods
Stata 11 for MacOSX (StataCorp LP, Texas, USA) was used for
statistical analyses. Stata 11 and Prism 5 for MacOSX (GraphPad
Software Inc., La Jolla, CA) were used for generation of graphs.
Data presented as median (range) unless otherwise stated.
Differences between gestational age groups were analyzed by
Kruskal-Wallis multiple comparisons test. Sex differences were
analyzed by Mann-Whitney U-test. Thiosulphate levels between
days for individuals were analyzed using Friedman repeated
measures ANOVA for non-parametric data and random effects
generalized least squares regression with bootstrapping. For
correlations, data was analyzed using Spearman r correlation or
transformed using natural logarithm (loge) and analyzed using
Pearson correlation, depending on the normality of data
distribution.
A Role for H2S in the Microcirculation of Newborns
PLOS ONE | www.plosone.org 3 August 2014 | Volume 9 | Issue 8 | e105085
Results
A total of 136 infants were recruited to the CANS2 Study. Due
to study design, only neonates with urine available for all three
days were included in this study. Therefore, 90 neonates were
studied for H2S turnover during circulatory transition. Their
clinical characteristics are shown in Table 1. Early discharge
policy led to fewer term infants but most clinical differences were
due to the effects of a priori allocation to different gestational age
groups or the known sexual dimorphism effects of fetal growth
[23].
Peripheral microvascular blood
Baseline microvascular blood flow demonstrated a significant
inverse relationship with gestational age at 6 hr (p,0.0001, r=2
0.54), 24 hr (p,0.0001, r=20.63) and 72 hr (p= 0.0003, r=2
0.38) postnatal age. As in previous studies [4], there was a strong
positive correlation between microvascular blood flow and Clinical
Risk Index for Babies (CRIB) II Score at 24 h postnatal age
(p = 0.0008, r=0.41). When split for sex, this relationship was
significant only in males (p = 0.0003, r=0.60). Also in line with
previous studies, baseline peripheral microvascular blood flow
exhibited significant relationships with measures of cardiovascular
function at 24 hr postnatal age. In neonates #36 weeks gestational
age at birth, baseline microvascular blood flow was inversely
related to mean arterial blood pressure (p = 0.0034, r=20.34).
This relationship with microvascular blood flow was observed for
both systolic (p = 0.0013, r=20.37) and diastolic pressure
(p = 0.0007, r=20.39). When analyzed by sex, this relationship
was observed in females only for all three measures (mean arterial
pressure: p = 0.0021, r=20.50; systolic blood pressure:
p = 0.0016, r=20.51; and diastolic pressure p= 0.0049, r=2
0.46).
H2S total body turnover
H2S turnover, as measured by urinary thiosulphate, over the
first 72 hr of postnatal life was highest in the very preterm
neonates, decreasing with increasing gestational age at birth
(p = 0.0001; Figure 1). H2S turnover on day 1 was lower in term
neonates (44.4 nmol/24 hr/kg; p = 0.03) but was comparable
between preterm and very preterm neonates (preterm: 80.6 nmol/
24 hr/kg, very preterm: 66.4 nmol/24 hr/kg; p= 0.17). H2S
turnover remained stable across the first 72 hours of life in term
and preterm neonates. However, in very preterm neonates, total
body turnover of H2S increased significantly from day 1 to 3
(p = 0.0001; Figure 2).
No significant effect of the other clinical variables outlined in
Table 1 was seen on microvascular blood flow or H2S turnover
after adjusting for the main effects of gestational age and sex.
Figure 1. H2S turnover over the first 72 hours of postnatal life. Thiosulphate, as a marker of H2S turnover, as measured in urine samples over
the first 3 days of life was lowest in term neonates and increased with increasing prematurity (Pearson correlation; p,0.0001, r =20.32).
doi:10.1371/journal.pone.0105085.g001
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Discussion
We have shown, for the first time, that in human infants there is
evidence of a role for the gasotransmitter H2S in the control of the
microvasculature. We have presented data showing being an at-
risk preterm infant increases the output of the major product of
H2S metabolism (thiosulphate). We have shown this to be related
independently to all the major risk factors for poor outcome
independently: gestational age, postnatal age and male sex.
Thiosulphate levels are comparable between preterm and very
preterm neonates for the first 24 h of postnatal life. However whilst
they remain low in older preterm neonates, levels increase
significantly from day 1 to day 2, and again from day 2 to day 3
in very preterm neonates. This suggests that very preterm neonates
are not born with inherently higher levels of H2S production, but
that H2S production increases significantly following birth.
Potential triggers for this would include oxidative stress [24] or
inflammation, both of which have been implicated in changes
following preterm delivery [25]. The findings that H2S turnover
increased postnatally in the very preterm group, but not in the
preterm group, and that microvascular blood flow was significantly
greater in the former also suggests that there is a physiological
difference between neonates born very preterm and those born at
later gestational ages. It also suggests that there are significant
developmental changes in the regulation of the gasotransmitter
production pathway throughout gestation and early postnatal life.
The positive relationship of H2S turnover with microvascular
blood flow and the inverse relationship with blood pressure in
more mature neonates suggests a physiological role of H2S in this
age group, perhaps as a counter to the overarching constrictive
balance [9], or as a reflection of an organ specific vascular
dilatation, such as in the pulmonary circulation [26,27]. This
remains an area of speculation and more research is required.
We observed a significant relationship between microvascular
blood flow at 24 hr postnatal age and day 2 urinary thiosulphate
levels in males ,37 weeks gestational age. This relationship was
not present in the very preterm group alone, despite these
neonates having the highest microvascular blood flow and the
highest thiosulphate excretion at this time. The lack of a conclusive
relationship suggests that dysregulation of microvascular tone may
not solely be the result of disturbances in H2S production, but may
result from an imbalance of vasoconstrictors and vasodilators,
including H2S. Previous work has shown that the other
gasotransmitters, NO and CO are both produced in, and exert
some effect on, the transitional microcirculation of preterm
neonates [10]. Further, it is possible that as in the state of
neonatal and adult shock a tight relationship between blood
pressure, microvascular tone and mediators is lost below a
threshold level [28,29].
It is becoming increasingly evident that microvascular function
is not controlled by the activity of these gasotransmitters working
in isolation, but by the interaction of all three, underlining the
complexity of hemodynamic microvascular control. It appears that
CO and H2S both play an important role during circulatory
transition and following the immediate extrauterine period, while
NO is critical for maintaining basal microvascular tone later, with
Figure 2. Urinary thiosulphate levels over the first three days of life. H2S turnover was stable across the first three days of life in term and
preterm neonates. In very preterm neonates, levels rose significantly over the first 72 hours of life (median6IQR). a-b-cp,0.0001 significant difference
across days in very preterm gestational age group (Friedman repeated measures ANOVA for non-parametric data).
doi:10.1371/journal.pone.0105085.g002
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significant effects of nitric oxide on hemodynamic status observed
in neonates at 7 days postnatal age [10,30]. In addition to the
vasodilators, a number of vasoconstrictive mediators also play a
role in the regulation of microvascular tone in the newborn.
Microvascular dysregulation in the preterm newborn is associated
with both impaired vasoconstriction [9] and abnormal peripheral
dilatation [10], contributing to cardiovascular compromise and
poor outcome, highlighting the importance of balance in
homeostasis and the profound effect imbalance can have on
physiological stability. Understanding the control of blood flow in
the perinatal period is a critical step for the development of
therapeutic strategies for the management of the newborn at risk
of cardiovascular compromise.
A number of groups suggest that H2S may play a role in central
cardiac function. In adults and experimental myocardial ischemia-
reperfusion models, H2S protects against cellular injury [31],
cardiomyocyte loss [32] and arrhythmias [33], reduces infarct size
[34], and improves microvascular reactivity [35] and cardiac
contractility [36]. Importantly, dysregulation of the H2S pathway
in adults has been implicated in a number of disease states,
including coronary heart disease and hypertension where
decreased plasma H2S levels, theoretically leading to a relative
state of vasoconstriction, correlate with disease severity [37,38].
H2S production is induced by shock states (inflammatory
[39,40], circulatory [41], septic [42], hemorrhagic [43] and
endotoxic [44,45]) and results in marked inflammation and injury.
These studies highlight the potent pro-inflammatory properties of
H2S and provide evidence for a pivotal role of H2S in the
pathophysiology of conditions associated with both local and
systemic inflammation and circulatory dysfunction. However, we
did not see any differences in H2S turnover between neonates with
or without sepsis, despite elevated levels expected in septic
patients. This may be due to the small numbers in the septic
group (n= 19 across sexes and gestational age groups) or the fact
that many neonates in the ‘‘non-septic’’ group may have
subclinical levels of sepsis and may have slightly elevated H2S
production, confounding the comparison. Further investigation
and comparison between a larger population of confirmed healthy
and septic newborns is required.
H2S is produced from the amino acids cysteine, homocysteine
and cystathionine by the activity of cystathionine-c-lyase (cy-
stathionase; CSE, EC 4.4.1.1), cystathionine-b-synthase (CBS, EC
4.2.1.22) or 3-mercaptopyruvate sulphurtransferase (MPST, EC
2.8.1.2).[46] Considerable research has been conducted into the
activity of CSE, the enzyme responsible for converting cystathi-
onine to cysteine via the transsulphuration pathway in the preterm
neonate. CSE activity is gestational- and postnatal-age dependent,
with significantly higher levels of hepatic activity in full term than
preterm newborns [47]. This hepatic activity is known to increase
during fetal-to-neonatal transition, such that the newborn exhibits
significantly higher activity compared to the fetus, with signifi-
cantly increased levels of both mRNA and protein [48,49]. The
results of the present study, which show a high total body turnover
of H2S in the initial extrauterine period, are at odds with earlier
reports of CSE activity being lower in preterm than term
newborns [47]. This may be a result of tissue specific regulation:
previous studies have looked only at hepatic activity, whereas our
results reflect total body H2S turnover. These earlier studies looked
at the conversion of cystathionine to cysteine as the end point of
the CSE mediated pathway, however, CSE is also responsible for
the further downstream metabolism of cysteine which results in
H2S production, and this second role, which was not previously
studied, may result in an accelerated breakdown of cysteine in the
preterm neonate, contributing to high levels of H2S during
Figure 3. Sex differences in thiosulphate levels in very preterm neonates in early postnatal life (median6IQR). H2S turnover, measured
as urinary thiosulphate excreted per day per kg body weight, was significantly higher in males than females on both day 1 (*p= 0.01) and day 2
(**p = 0.04) of postnatal life (Friedman repeated measures ANOVA for non-parametric data).
doi:10.1371/journal.pone.0105085.g003
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circulatory transition. Additionally, high H2S production could
also occur in the absence of high endogenous cysteine as CSE can
also use homocysteine and cystathionine as substrates to produce
H2S [50].
It is also possible that the CSE arm of the H2S production
pathway is not the predominant player in H2S production during
the perinatal period. CBS and MPST are also known to catalyze
the production of H2S. The concept of H2S production enzymes
following a tissue-specific expression profile is currently being
challenged. Until recently, it was believed that the major source of
H2S in the vasculature was CSE. More recently it has been shown
that CBS, the enzyme originally thought to be responsible for H2S
production predominantly in the brain and nervous tissue, is also
expressed in the vasculature, and a third, more recently discovered
pathway for synthesizing H2S via MPST has also been identified
in rodent vasculature [51]. Little is known about these three
production pathways in the human vasculature or in the neonatal
period. Neonatal CBS deficiency manifests as homocystinuria
associated with neurodevelopmental delay and skeletal and
vascular abnormalities, highlighting the importance of this
pathway not only in the brain, but in a number of other systems,
including the vasculature [52]. Clearly future studies will need to
address all enzymes in the H2S production pathway. Further
elucidation of the activity of these enzymes will help to define
possible intervention strategies.
A limitation of our study is that whilst we have demonstrated a
clear correlation between outcome, microvascular blood flow and
H2S production, this does not prove causation. Nevertheless we
believe that our study provides strong clinical data that this
pathway is involved in microvascular tone regulation during
circulatory transition. Furthermore, it highlights both the need for
mechanistic studies utilising available animal models [13,53], and
alternative measures of H2S production. Exhaled H2S may
provide us with better temporal resolution of H2S production [54].
These results provide the first evidence that H2S may play a role
in maintaining microvascular tone of the neonate in the perinatal
period. Thiosulphate levels (as a marker of total body turnover of
H2S) were found to be highest in those neonates at greatest risk of
microvascular dysfunction characterized by inappropriate periph-
eral vasodilatation – very preterm male neonates born at 28 weeks
completed gestation or less, suggesting that overproduction of H2S
may contribute to microvascular dysfunction in neonates and thus
to both their mortality and long term morbidity. The hydrogen
sulphide pathway potentially represents a novel therapeutic target
for the selective control of vascular tone and development during
fetal-to-neonatal circulatory transition, which may help to reduce
Figure 4. Relationship between baseline microvascular blood flow at 24 hr and H2S turnover on day 2 of postnatal life. H2S turnover
(measured as urinary thiosulphate) was significantly correlated with baseline microvascular blood flow in preterm male neonates 29–36 wk GA
(Pearson correlation; p = 0.04, r= 0.43). No relationship was observed for females of the same gestational age, very preterm neonates (24–28 wk GA)
or term neonates (37+wk GA).
doi:10.1371/journal.pone.0105085.g004
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cardiovascular compromise following preterm birth, leading to
better short- and long- term outcomes for this vulnerable group.
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